# Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon

> **NCT01858428** · NA · COMPLETED · sponsor: **Spectranetics Corporation** · enrollment: 300 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** Cardiovascular Ingenuity (CVI) Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter
- **DEVICE:** EverCross Percutaneous Transluminal Balloon Catheter

## Key facts

- **NCT ID:** NCT01858428
- **Lead sponsor:** Spectranetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-18
- **Primary completion:** 2016-09
- **Final completion:** 2018-03-19
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2020-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01858428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01858428, "Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01858428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*